1 . Reutens AT, Atkins RC. Epidemiology of Diabetic Nephropathy. Contributions to. nephrology. 2011; 170: 1-7.
2 . Gembillo G, Cernaro V, Salvo A, Siligato R, Santoro D. Role of Vitamin D Status in Diabetic Patients with Renal Disease. Medicina (Kaunas, Lithuania). 2019; 55(6): 273-279.
3 . Keri KC, Samji NS, Samuel B. Diabetic Nephropathy: Newer Therapeutic Perspectives. Journal of Community Hospital Internal Medicine Perspectives. 2018; 8(4):200-207.
4 . Yang H, Kan QE, Su Y, Man H. Long non-coding RNA CASC2 improves diabetic nephropathy by inhibiting JNK pathway. Experimental & Clinical Endocrinology & Diabetes. 2019, 127(8):533-537.
5 . Wang J, Li H, Tan M, Gao G, Zhang Y, Ding B, Su X, Kong XC, Ma JH. Association between Thyroid Function and Diabetic Nephropathy in Euthyroid Subjects with Type 2 Diabetes Mellitus: A Cross-Sectional Study in China. Oncotarget. 2019;102(2):88-97.
6 . Wu LC, Lin X, Sun H. Tanshinone ⅡA Protects Rabbits against LPS-Induced Disseminated Intravascular Coagulation (Dic). Acta Pharmacologica Sinica. 2012;33(10):1254-1259.
7 . Nickavar B, Rezaee J, Nickavar A. Iranian Effect-Directed Analysis for the Antioxidant Compound in Salvia erticillata. Iran J Pharm Res. 2016;15 (1) :241-246.
8 . Liu X, Meng J. Tanshinone ⅡA Ameliorates Lipopolysaccharide-Induced Inflammatory. Response in Bronchial Epithelium Cell Line BEAS-2B by Down-Regulating MiR-27a. Biomedicine & pharmacotherapy.2018;104:158-164.
9 . Kim EJ, Jung SN, Son KH, Kim SR, Ha TY, Park MG, Jo IG, Park JG, Choe WC, Kim S, Ha J. Antidiabetes and Antiobesity Effect of Cryptotanshinone Via Activation of Amp-Activated Protein Kinase. Molecular pharmacology. 2007;72(1):62-72.
10 . Zhang JY, Liang RX, Wang L, Yang B. Effects and Mechanisms of Danshen-Shanzha Herb-Pair for Atherosclerosis Treatment Using Network Pharmacology and Experimental Pharmacology. Journal of Ethnopharmacology. 2019; 229:104-114.
11 . Chen LD, Cao Y, Zhang H, Lv DY, Zhao YH, Liu YJ, Ye G, Chai YF. Network. Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of Yang Xin Shi Tablet for Treating Heart Failure. Journal of ethnopharmacology. 2018; 219:359-368.
12 . Xu J, Wang F, Guo JJ, Xu CS, Cao YZ, Fang ZL, Wang QW. Pharmacological Mechanisms Underlying. the Neuroprotective Effects of Alpinia Oxyphylla Miq. On Alzheimer's Disease. International journal of molecular sciences. 2020; 21(6):2071-2085.
13 . Ding ZH, Zhong RX, Yang YN, Xia TY, Wang WJ, Wang Y, Xing N, Luo Y, Li SY, Shang LF. Systems Pharmacology Reveals the Mechanism of Activity of Ge-Gen-Qin-Lian Decoction against LPS-Induced Acute Lung Injury: A Novel Strategy for Exploring Active Components and Effective Mechanism of TCM Formulae. Pharmacological Research. 2020; 156:1047-1059.
14 . Zhang YQ, Mao X, Guo QY, Lin N, Li S. Network Pharmacology-Based Approaches Capture Essence of Chinese Herbal Medicines. Chinese Herbal Medicines. 2016;8(2):107-116.
15 . Consortium TU. Reorganizing the Protein Space at the Universal Protein Resource (Uniprot). Nucleic Acids Research.2012;40(D1):71-75.
16 . Damian S, Annika LG, David L, Alexander J, Wyder S, Jaime HC, Milan S, Nadezh TD, John HM, Peer B, Jensen LJ, Mering CV. String V11: Protein–Protein Association Networks with Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets. Nucleic acids research. 2019; 47(D1):607-613.
17 . Huang C, Li R, Shi W, Huang Z. Discovery of the Anti-Tumor Mechanism of. Calycosin against. Colorectal Cancer by Using System Pharmacology Approach. Med Sci Monit. 2019; 25:5589-5593.
18 . Damian S, Andrea F, Stefan W, Kristoffer F, Davide H, Jaime H C, Milan S, Alexander R, Alberto S, Tsafou KP. String V10: Protein–Protein Interaction Networks, Integrated over the Tree of Life. Nucleic Acids Research. 2015;43(D1):447-452.
19 . Zhou YY, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets. Nature Communications. 2019; 10(1):1523-1533.
20 . Kim SK, Jung KH, Lee BC. Protective Effect of Tanshinone ⅡA on the Early Stage of Experimental Diabetic Nephropathy. Biological & Pharmaceutical Bulletin. 2009; 32(2):220-224.
21 . Luo P, Tan ZH, Zhang ZF, Li HH, Mo Z. Inhibitory Effects of Salvianolic Acid B on the High. Glucose-Induced Mesangial Proliferation Via NF-kappaB-dependent Pathway. Biological & Pharmaceutical Bulletin. 2008;31(7):1381-1386.
22 . Berman H, Henrick K, Nakamura H. Announcing the Worldwide Protein Data Bank. Nature. Structural Biology. 2003;10(12):980.
23 . Ding L, Jin DZ, Chen XL. Luteolin Enhances Insulin Sensitivity Via Activation of Pparγ Transcriptional Activity in Adipocytes. Journal of Nutritional Biochemistry. 2010; 21(10):941-947.
24 . Lu HE, Chen Y, Sun XB, Tong B, Fan XH. Effects of Luteolin on Retinal Oxidative Stress and Inflammation in Diabetes. Rsc Advances. 2015;5(7):4898-4904.
25 . Liu JF, Ma Y, Wang Y, Du ZY, Shen JK, Peng HL. Reduction of Lipid. Accumulation in Hepg2 Cells by Luteolin is Associated with Activation of AMPK and Mitigation of Oxidative Stress. Phytotherapy Research. 2011; 25(4):588-596.
26 . Amenedo M, Residential R. EGFR Mutations and ALK Alterations in Never-smoking Lung. Cancer Cases. European Respiratory Journal. 2016,48(5):1462-1470.
27 . Gao HW, Liu X, Sun W, Kang NX, Liu YL, Yang SL, Xu QM, Wang CM, Chen XP. Total Tanshinones Exhibits Anti-Inflammatory Effects through Blocking TLR4 Dimerization Via the MyD88 Pathway. Cell Death & Disease. 2017;8(8): e3004.
28 . Chen X, Wu R, Kong YW, Yang YT, Gao Y, Sun DD, Liu QZ, Dai DJ, Lu ZY, Wang NS, Ge S, Wang F. Tanshinone IIA Attenuates Renal Damage in STZ-Induced Diabetic Rats Via Inhibiting Oxidative Stress and Inflammation. Oncotarget. 2017;8(19):31915-31922.
29 . Zhai JH, Tao L, Zhang YM, Gao H, Qu XY, Song YQ, Zhang SX. Salvianolic Acid B Attenuates Apoptosis of HUVEC Cells Treated with High Glucose or High Fat Via Sirt1 Activation. Evidence-Based Complementary and Alternative Medicine. 2019;2019(21):1-11.
30 . Zhang YF, Xu LW, Liang K, Zhou LH, Ge YZ, Jia RP. Protective Effect of. Salvianolic Acid B against Oxidative Injury Associated with Cystine Stone Formation. Urolithiasis. 2019; 47(6):503-510.
31 . Liu QM, Shi XG, Tang LY, Xu WH, Jiang S, Ding WF, Feng Q, Chu HY, Ma YY, Li Y, Lu JY, Pu WL, Zhou XD, Li J, Wang JC, Wu WY. Salvianolic Acid B Attenuates Experimental Pulmonary Inflammation by Protecting Endothelial Cells against Oxidative Stress Injury. European Journal of Pharmacology. 2018; 840: 9-19.
32 . Wang QQ, Zhai C, Wahafu A, Zhu YT, Liu YH, Sun LQ. Salvianolic AcidB Inhibits. the Development of Diabetic Peripheral Neuropathy by Suppressing Autophagy and Apoptosis. The Journal of pharmacy and pharmacology. 2019;71(3):417-428.
33 . Liu QM, Lu JY, Lin JR, Tang YL, Pu WL, Shi XG, Jiang S, Liu J, Ma YY, Li Y, Xu JH, Li J, Wang JC, Wu WY. Salvianolic Acid B Attenuates Experimental Skin Fibrosis of Systemic Sclerosis. Biomedicine & Pharmacotherapy. 2019;110: 546-553.
34 . Li J, Zhang CT, He WM, Qiao HZ, Chen JH, Wang KK, Oupick D, Sun M. Coordination-Driven Assembly of Catechol-Modified Chitosan for the Kidney-Specific Delivery of Salvianolic Acid B to Treat Renal Fibrosis. Biomater Sci. 2017;6(1):179-188.
35 . Patel RK, Mohan C. PI3K/AKT Signaling and Systemic Autoimmunity. Immunologic research. 2005; 31(1):47-55.
36 . Ribback S, Cigliano A, Kroeger N, Pilo MG, Dombrowski F. PI3K/AKT/MTOR Pathway Plays a Major Pathogenetic Role in Glycogen Accumulation and Tumor Development in Renal Distal Tubules of Rats and Men. Oncotarget. 2015;6(15):13036-13048.
37 . Yi HY, Zhang Y, Yang XF, Li MY, Hu HF, Xiong J, Wang N, Jin JY, Zhang YS, Song Y, Wang X, Chen LH, Lian JQ. Hepatitis B Core Antigen Impairs the Polarization While Promoting the Production of Inflammatory Cytokines of M2 Macrophages Via the TLR2 Pathway. Frontiers in Immunology. 2020;11: 535-549.
38 . Onions K, Gamez M, Buckner N, Baker S, Betteridge K, Desideri S, Dallyn B, Ramnath R, Neal C, Farmer L, Mathieson P, Gnudi L, Alitalo K, Bates D, Salmon A, Welsh G, Satchell S, Foster R. VEGFC Reduces Glomerular Albumin Permeability and Protects against Alterations in VEGF Receptor Expression in Diabetic Nephropathy. Diabetes. 2019;68 (1):172-187.
39 . Zheng X, Zhao YJ, Zhong P, Wang JY, Weng QY, Qian YY, Han JB, Zou CP, Liang G. EGFR Inhibition Attenuates Diabetic Nephropathy through Decreasing ROS and Endoplasmic Reticulum Stress. Oncotarget. 2017;8(20):32655-32667.
40 . Lu P, Ji X, Wan J, Xu H. Activity of Group 2 Innate Lymphoid Cells Is Associated with Chronic. Inflammation and Dysregulated Metabolic Homoeostasis in Type 2 Diabetic Nephropathy. Scandinavian Journal of Immunology. 2017;87(2):99-107.
41 . Tesch GH. Diabetic nephropathy-is this an immune disorder?. Clin Sci (Lond). 2017, 131 (16): 2183-2199.
42 . Fathy SA, Mohamed MR, Ali MM, El-Helaly AE, Alattar AT. Influence of IL-6, IL-10, IFN-γ and TNF-α Genetic Variants on Susceptibility to Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. Biomarkers. 2019,24(1):43-55.
43 . Wu N, Shen H, Liu H, Wang Y, Bai Y, Han P. Acute blood glucose fluctuation. enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo. Cardiovasc Diabetol. 2016;15(1):109-121.
44 . Lamont BJ, Drucker DJ. Differential Antidiabetic Efficacy of Incretin Agonists. Versus Dpp-4 Inhibition in High Fat Fed Mice. Diabetes. 2008;57(1):190-198.
45 . Moritoh Y, Takeuchi K, Asakawa T, Kataoka O, Odaka H. Chronic Administration of. Alogliptin, a Novel, Potent, and Highly Selective Dipeptidyl Peptidase-4 Inhibitor, Improves Glycemic Control and Beta-Cell Function in Obese Diabetic Ob/Ob Mice. European Journal of Pharmacology. 2008;588(2-3):325-332.
46 . Tobon-Velasco JC, Cuevas E, Torres-Ramos MA. Receptor for Ages (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress. CNS & Neurological Disorders-Drug Targets. 2014; 13(9):1615-1626.
47 . Pang RY, Guan MP, Zheng ZJ, Xue YM. Effects of Metformin on Apoptosis. Induced by Advanced. Glycation End-Products and Expressions of Caspase-3, Bax and Bcl-2 in Human Dermal Fibroblasts in Vitro. Journal of Southern Medical University. 2015;35(6):898-902.
48 . Liu FX, Fu YC, Wei CJ, Chen YR,Ma SH, Xu WC. The Expression of GPR109A, NF-kB and Il-1β in Peripheral Blood Leukocytes from Patients with Type 2 Diabetes. Ann Clin Lab Sci. 2014;44(4):443-448.
49 . Yamagishi SI, Matsui T. Role of Ligands of Receptor for Advanced Glycation End Products (RAGE) in Peripheral Artery Disease. Rejuvenation Research. 2018; 21:456-463.
50 . Rakitianskaia IA, Riabov SI, Azanchevskaia SV, Riabova TS, Popova VB. Role of Intrarenal. Product TNF-Alpha in the Development of Glomerular and Tubulointerstitial Tissues Changes in Elderly Patients with Diabetic Nephropathy. adv gerontol. 2013; 26(4):658-665.
51 . Moresco RN, Sangoi MB, Carvalho JM, Tatsch E, Bochi GV. Diabetic Nephropathy: Traditional to Proteomic Markers. Clinica chimica acta. 2013; 421: 17-30.
52 . Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, Sytwu HK, Lin YF. Aberrant. Cytokines/Chemokines Production Correlate with Proteinuria in Patients with Overt Diabetic Nephropathy. Clinica Chimica Acta. 2010; 411(9-10):700-704.
53 . Liu QJ, Xing LL, Wang L, Yao F, Liu SX, Hao J, Liu W, Duan HJ. Therapeutic. Effects of. Suppressors of Cytokine Signaling in Diabetic Nephropathy. J Histochem Cytochem. 2014;62(2):119-128.
54 . Debbie W, Hani A M, Daniel L, Ariel T, Leonid K, Ralph R, Yael S. Impaired Renal Growth Hormone JAK/STAT5 Signaling in Chronic Kidney Disease. Nephrol Dial Transplant. 2014,29(4):791-799.
55 . Zhou YH, Lv C, Wu C, Chen FQ, Shao Y, Wang QY. Suppressor of Cytokine. Signaling (Socs) 2 Attenuates Renal Lesions in Rats with Diabetic Nephropathy. Acta Histochemica. 2014; 116(5): 981-988.
56 . Shi WX, Li N, Sui MS. Research Progress of Foxo in Kidney Diseases. Journal of Chinese Practical Diagnosis and Therapy.2018;32(2):205-208.
57 . Du MM, Wang QZ, Li W, Ma XJ, Wu L, Guo F, Zhao SY, Huang FJ, Wang HH, Qin GJ. Overexpression of Foxo1 Ameliorates the Podocyte Epithelial–Mesenchymal Transition Induced by High Glucose In vitro and In vivo. Biochemical & Biophysical Research Communications. 2016;471(4):416-422.